Flexibility Wins: Displaying Futures Award 2017

MerckHave you stretched your imagination? Achieved a breakthrough innovation in the field of wearable health monitors or soft robotics and electronic skin? In sensors or electronics packaging? Are you dreaming of realizing your idea? If so, Merck wants to hear from you.

Merck will select the best three teams out of applications from all over the world. Every team will receive up to US$ 50,000 to explore and realize their idea. Over the course of 12 months, Merck will provide each team exclusive mentorship and coaching according to their individual needs, for example in business plan development and prototype building. There is only a need for being presence during the defined events.

Topics for Displaying Futures Award 2017

The focus of the 2017 award is Innovative flexible hybrid electronic devices enabled by advanced materials. Merck is looking for break-through innovations in:
  • wearables for health monitoring
  • soft robotics and electronic skin
  • sensors and electronics packaging

The application period closes on May 19, 2017. A jury of Merck experts will select up to ten teams and ideas on the basis of innovativeness, business potential and social impact. The jury will be headed by Executive Vice President Dr. Michael Heckmeier, Head of the Display Materials business unit within the Performance Materials business sector of Merck.

Merck will invite the selected teams to participate in the kick-off bootcamp and to pitch their idea at the Merck Innovation Center in Darmstadt, Germany. The bootcamp and pitch day for all teams are planned for June 2017. Travel costs will be reimbursed for two members of each team (up to US$ 3,000 per team). Out of the pitches, the jury will select up to three winners of the Displaying Futures Award. In addition, the aforementioned support, the three winning teams will be invited in December 2017 for a mid-way pitch and a second bootcamp. At the end of the 12 months, a final event will take place for all teams, including a pitch in front of potential investors.

For further information and to apply, please visit:
https://df-award-2017.hypego.net

About Merck
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15.0 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Most Popular Now

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Digital ECGs at Barts Health: A High-Imp…

Opinion Article by Dr Krishnaraj Sinhji Rathod, consultant in interventional cardiology, Barts Health NHS Trust. Picture the moment. A patient in an ambulance, enroute to hospital with new chest pain. Paramedics...

Study Sheds Light on Hurdles Faced in Tr…

Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools...

Using Deep Learning for Precision Cancer…

Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in Nature Communications, the...

New AI Approach Paves Way for Smarter T-…

Researchers have harnessed the power of artificial intelligence (AI) to tackle one of the most complex challenges in immunology: predicting how T cells recognize and respond to specific peptide antigens...

Study Used AI Models to Improve Predicti…

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of the...

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...